Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-May-24 8:32 PM View:  | Dynavax Technologies Corp. (DVAX) | 23-May-24 | Grant | 5,357 | -- | -- | 27% 20.09K to 25.45K | |
| 11-Mar-24 5:24 PM View: | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 22,665 | -- | -- | (100%) 22.66K to 0 | |
| 03-Jan-24 4:30 PM View: | Harpoon Therapeutics, Inc. (HARP) | 01-Jan-24 | Grant | 2,048 | -- | -- | 10% 20.62K to 22.67K | |
| 28-Nov-23 4:26 PM View: | Harpoon Therapeutics, Inc. (HARP) | 27-Nov-23 | Grant | 5,000 | -- | -- | 32% 15.62K to 20.62K | |
| 02-Oct-23 10:00 PM View: | Harpoon Therapeutics, Inc. (HARP) | 01-Oct-23 | Grant | 5,797 | -- | -- | 59% 9.82K to 15.62K | |
| 06-Jul-23 6:34 PM View: | Harpoon Therapeutics, Inc. (HARP) | 01-Jul-23 | Grant | 35,634 | -- | -- | 57% 62.58K to 98.22K | |
| 31-May-23 5:35 PM View: | Dynavax Technologies Corp. (DVAX) | 26-May-23 | Grant | 5,357 | -- | -- | 36% 14.73K to 20.09K | |
| 12-Apr-23 7:05 PM View: | Viridian Therapeutics, Inc.... (VRDN) | 12-Apr-23 | Market Purchase | 4,000 | $25.37 | $101,479.00 | 2% 255.5K to 259.5K | (9%) |
| 04-Apr-23 5:06 PM View: | Harpoon Therapeutics, Inc. (HARP) | 01-Apr-23 | Grant | 34,925 | -- | -- | 126% 27.66K to 62.58K | |
| 13-Mar-23 4:06 PM View: | Viridian Therapeutics, Inc.... (VRDN) | 13-Mar-23 | Purchase | 5,500 | $29.15 | $160,324.00 | 2% 250.0K to 255.5K | |
| 07-Feb-23 6:55 PM View: | Viridian Therapeutics, Inc.... (VRDN) | 06-Feb-23 | Grant | 250,000 | -- | -- | 100% 0 to 250.0K | |
| 26-Dec-19 5:29 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 23-Dec-19 | Grant | 39,409 | $1.46 | $57,537.10 | 95% 41.44K to 80.84K | |
| 20-Aug-19 4:32 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 20-Aug-19 | Grant | 41,436 | $1.81 | $74,999.20 | 100% 0 to 41.44K | 81% |
| 13-Mar-18 6:07 PM View: | Oncothyreon Inc (CASC) | 09-Mar-18 | Disposition (change in control) | 56,787 | -- | -- | (100%) 56.79K to 0 | |
| 16-Jan-18 5:26 PM View: | Oncothyreon Inc (CASC) | 11-Jan-18 | Payment of Exercise | 3,429 | $3.92 | $13,441.70 | (6%) 60.22K to 56.79K | |
| 16-Jan-18 5:26 PM View: | Oncothyreon Inc (CASC) | 11-Jan-18 | Option Exercise | 10,500 | -- | -- | 21% 49.72K to 60.22K | |
| 14-Aug-17 5:12 PM View: | Oncothyreon Inc (CASC) | 11-Aug-17 | Market Purchase | 5,500 | $3.73 | $20,542.50 | 12% 44.22K to 49.72K | 170% |
| 16-May-17 5:43 PM View: | Oncothyreon Inc (CASC) | 12-May-17 | Market Purchase | 2,800 | $4.00 | $11,191.60 | 7% 41.42K to 44.22K | 152% |
| 04-Apr-17 5:39 PM View: | Oncothyreon Inc (CASC) | 31-Mar-17 | Market Purchase | 2,000 | $4.11 | $8,228.60 | 5% 39.42K to 41.42K | 145% |
| 21-Mar-17 8:09 PM View: | Oncothyreon Inc (CASC) | 20-Mar-17 | Market Purchase | 1,000 | $3.93 | $3,927.10 | 3% 38.42K to 39.42K | 157% |
| 31-Jan-17 4:55 PM View: | Oncothyreon Inc (CASC) | 27-Jan-17 | Market Purchase | 20,500 | $3.76 | $77,039.00 | 114% 17.92K to 38.42K | 168% |
| 18-Aug-16 5:16 PM View: | Oncothyreon Inc (CASC) | 17-Aug-16 | Market Purchase | 45,000 | $1.15 | $51,745.50 | 72% 62.5K to 107.5K | 45% |
| 28-Jun-16 5:36 PM View: | Oncothyreon Inc (CASC) | 28-Jun-16 | Private Purchase | 62,500 | $0.80 | $50,000.00 | 100% 0 to 62.5K | |
| 26-May-06 1:50 PM View: | DOV Pharmaceutical Inc. (DOVP.OB) | 25-May-06 | Market Purchase | 5,000 | $2.69 | $13,450.00 | 100% 5.0K to 10.0K | (99%) |
| 26-May-06 1:50 PM View: | DOV Pharmaceutical Inc. (DOVP.OB) | 24-May-06 | Market Purchase | 5,000 | $2.69 | $13,450.00 | 100% 0 to 5.0K | (99%) |